Studies from National Health Insurance Corporation Ilsan Hospital, Department of Ophthalmology in the area of diabetes therapy published
Scientists discuss in 'A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy' new findings in diabetes. In this recently published article, scientists in Korea conducted a study "To screen for diabetic autonomic neuropathy of the pupil using 0.5% apraclonidine and 0.1% pilocarpine and to evaluate the early diagnostic value of this pharmacologic pupillary test by assessing the relationship between pupillary and cardiovascular autonomic neuropathies. A total of 22 diabetic patients were recruited."
"Baseline pupillary diameter (PD) and the difference in PD between the test eye and the control eye before and after instillation of apraclonidine and pilocarpine were measured. All patients also underwent cardiovascular autonomic function (CAF) testing. Baseline PD in room light correlated with duration of diabetes mellitus (DM, p=0.049) and the presence of DM retinopathy (DMR, p=0.022). Eleven patients (50%) had positive apraclonidine tests, and two patients had positive pilocarpine tests. The patients who had positive pilocarpine tests also had positive apraclonidine tests. Patients who had a positive pupillary test had a significantly higher rate of positive CAF tests (p=0.032). Pupillary autonomic neuropathy was related to the duration of diabetes and the degree of DMR. There was also a significant correlation between pupillary autonomic neuropathy and cardiovascular autonomic neuropathy (CAN). Also, sympathetic nerve dysfunction occurred prior to parasympathetic dysfunction in this study," wrote H.J. Kwon and colleagues, National Health Insurance Corporation Ilsan Hospital, Department of Ophthalmology (see also Diabetes Therapy).
The researchers concluded: "A simple pharmacologic pupillary test can help manage complications in diabetic patients because patients with pupillary autonomic dysfunction have an increased risk of CAN."
Kwon and colleagues published their study in Korean Journal of Ophthalmology (A pharmacologic pupillary test in the diagnosis of diabetic autonomic neuropathy. Korean Journal of Ophthalmology, 2009;23(4):291-5).
For more information, contact H.J. Kwon, National Health Insurance Corporation Ilsan Hospital, Dept. of Ophthalmology, #1232 Baekseok-dong, Ilsandong-gu, Goyang, Korea.


Advisor News
- Finseca and IAQFP announce merger
- More than half of recent retirees regret how they saved
- Tech group seeks additional context addressing AI risks in CSF 2.0 draft profile connecting frameworks
- How to discuss higher deductibles without losing client trust
- Take advantage of the exploding $800B IRA rollover market
More Advisor NewsAnnuity News
- Somerset Re Appoints New Chief Financial Officer and Chief Legal Officer as Firm Builds on Record-Setting Year
- Indexing the industry for IULs and annuities
- United Heritage Life Insurance Company goes live on Equisoft’s cloud-based policy administration system
- Court fines Cutter Financial $100,000, requires client notice of guilty verdict
- KBRA Releases Research – Private Credit: From Acquisitions to Partnerships—Asset Managers’ Growing Role With Life/Annuity Insurers
More Annuity NewsHealth/Employee Benefits News
- Cigna hails pharmacy deal with the FTC, battles elevated cost trends
- Health care inflation continues to eat away at retirement budgets
- Pharmacy benefit manager (PBM) reform included in government funding package
- Health insurance CEOs say they lose money in Obamacare marketplace despite subsidies
- Blood test for colorectal cancer screening now available for military in La.
More Health/Employee Benefits NewsLife Insurance News